
Last updated: 2026-10-29 · Written by: SaiyanMed Research Team · Reading time: about 22 minutes · Scope: in-vitro laboratory handling of a research reagent
Quick answer: AOD9604 (YLRIVQCRSVEGSCGF, Cys7–Cys14 disulfide, 1815.1 g/mol as the free peptide) is only weakly basic. By our calculation it carries about +1 net charge from pH 5 to 7, rising to roughly +2.7 to +3 at pH 2–3. Its calculated pI is 8.8–9.9, depending on the pKa set.[2][5] The only published water-solubility figure for the material is about 2 mg/mL, from a supplier COA cited by FDA.[1] Most cloudy vials have one of three causes: the concentration is above that figure; a neutral diluent was the first liquid to touch a hydrophobic, low-charge peptide; or the solution was agitated. For a laboratory stock, the standard approach is to wet the powder with a small volume of dilute acetic acid, check that it is clear, and then dilute. That is the generic rule for basic peptides, and it is also how the originator handled the peptide during manufacture.[6][10][11] Then verify. Clarity alone does not tell you whether the peptide aggregated or degraded.
Key takeaways
- Concentration comes first. FDA cites a COA giving water solubility of up to 2 mg/mL. The popular ‘5 mg in 2 mL’ preparation is 2.5 mg/mL, which is already above that figure.[1]
- Charge is modest at neutral pH. We calculate about +1 at pH 7 with three pKa sets, against about +2.7 to +3 in 0.6% acetic acid (pH ≈ 2.9). That two- to threefold gain in charge is the real reason acid works. The method is shown below.
- Many calculators get the pI wrong. Tools that count both cysteines as free thiols report a pI of about 8.1. AOD9604’s cysteines are in a disulfide, so they should be excluded, which gives 8.8–9.9.
- Use a little acid, not a lot. The originator dissolved crude peptide in 25% acetic acid during processing. The same patent shows acid-driven Gln deamidation and hydrolysis in a dry HCl-salt form. Use acid only to wet the powder, then dilute, aliquot and freeze.[6]
- The disulfide prefers acid. Thiol–disulfide exchange runs through the thiolate anion, so it slows sharply at low pH. Ammonia and basic buffers work against you on both charge and chemistry.[14][11]
- Verify before you trust a clear vial. Measure supernatant A280 after centrifugation. Compare it before and after filtration. Check SEC or RP-HPLC recovery and intact mass. A practical trap: a disulfide-linked dimer at 4+ has the same m/z as the monomer at 2+.
Contents
- What AOD9604 is (and is not)
- Charge and pI, recomputed with three pKa sets
- Why it clouds or gels: the mechanism
- What the primary sources actually say
- Solvent choice, including bacteriostatic water
- Acid-first laboratory method
- Troubleshooting decision tree
- Verification: aggregation vs degradation
- Storage
- Myths versus evidence
- How this guide differs from common advice
- Glossary
- FAQ
What AOD9604 is (and is not)
Mature human growth hormone (UniProt P01241, 191 residues) ends in …FLRIVQCRSVEGSCGF, residues 176–191, with a disulfide between Cys182 and Cys189.[5] AOD9604 is hGH 177–191 with an extra tyrosine on the N-terminus. FDA describes it as a hexadecapeptide made of the 15-residue 177–191 fragment plus Tyr, and the developer’s own papers use the same hexadecapeptide description.[1][20][21] Because native position 176 is phenylalanine, AOD9604 can also be read as hGH 176–191 with Phe176 replaced by Tyr. That is why the material is sold under several names that are easy to confuse.
| Property | Value | Source |
|---|---|---|
| Sequence | H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (YLRIVQCRSVEGSCGF) | [2][1] |
| Disulfide | Cys7–Cys14, which corresponds to hGH Cys182–Cys189 | [2][5] |
| Free peptide | C78H123N23O23S2, 1815.1 g/mol; monoisotopic 1813.860 Da | [2] |
| Acetate (1:1) | C80H127N23O25S2, 1875.1 g/mol. Real lots carry a variable amount of acetate; Cayman writes ·XC2H4O2 | [3][8] |
| Identifiers | CAS 221231-10-3; UNII 7UP768IP4M; PubChem CID 71300630. FDA notes that some suppliers use other CAS numbers, such as 386264-39-7, and that supplier structures are not always consistent | [1][4] |
| Ionisable groups | N-terminal amine, Arg3, Arg8 (basic); Glu11, C-terminal carboxyl, Tyr1 phenol (acidic). No Lys, no His, no free Cys | Sequence |
| Hydrophobic side chains | Tyr1, Leu2, Ile4, Val5, Val10, Phe16: 6 of 16 | Sequence |
| Supplier solid storage | −20 °C, ≥ 4 years (Cayman) | [8] |
Two supplier documents contain errors that are worth knowing about. Cayman’s product sheet calls the material a ’15-amino acid peptide’, but the sequence has 16 residues.[8] InvivoChem lists the synonym ‘Tyr-somatostatin (177-191)’, but somatostatin is a 14-residue hormone with no 177–191 region.[9] The structural background is covered in our AOD-9604 structure and sequence analysis and in What Is AOD9604.
Charge and pI, recomputed with three pKa sets
Method. The net charge z(pH) is the sum of Henderson–Hasselbalch fractions. Each basic group contributes +1/(1+10pH−pKa) and each acidic group contributes −1/(1+10pKa−pH). The pI is the pH at which z = 0, solved by bisection. We used one N-terminus, two Arg, one Glu, one Tyr and one C-terminus. Both cysteines are excluded because they form the disulfide. Our Python script reproduces Biopython’s Bjellqvist result exactly when the cysteines are included as free thiols (pI 8.06), which confirms the arithmetic.[22][24][25]
| pKa set (N-term / C-term / Arg / Glu / Tyr) | pI, disulfide intact | pI if Cys counted free (common error) | z pH 2 | z pH 3 | z pH 5 | z pH 7 | z pH 8 | z pH 10 |
|---|---|---|---|---|---|---|---|---|
| Lehninger (9.69 / 2.34 / 12.48 / 4.25 / 10.07) | 9.88 | 8.15 | +2.68 | +2.13 | +1.15 | +1.00 | +0.97 | −0.14 |
| EMBOSS, Epk.dat (7.5 / 3.6 / 12.5 / 4.1 / 10.1)[22] | 8.80 | 7.80 | +2.97 | +2.73 | +1.15 | +0.76 | +0.23 | −0.45 |
| EMBOSS, older N-term 8.6 variant | 9.35 | 8.22 | +2.97 | +2.73 | +1.15 | +0.98 | +0.79 | −0.41 |
| Bjellqvist / ExPASy (7.5 / 3.55 / 12.0 / 4.45 / 10.0)[24][25] | 8.75 | 8.06 | +2.97 | +2.75 | +1.25 | +0.76 | +0.23 | −0.52 |

What the numbers mean. A pI of 8.8–9.9 is consistent with v1’s rough estimate of about 9.5. The more important result is the plateau: from pH 5 to pH 7, AOD9604 carries only about +1 net charge across all four sets. Moving to pH 2.9 (0.6% acetic acid) roughly triples that charge, because the C-terminal carboxyl and Glu11 become protonated. At pH 8, two of the four sets put the charge near +0.2. Ammonium hydroxide and basic buffers therefore remove almost all of the electrostatic repulsion between chains.
| Acetic acid (% w/v ≈ v/v) | Molarity | Calculated pH |
|---|---|---|
| 0.1% | 0.017 M | ≈ 3.3 |
| 0.6% | 0.10 M | ≈ 2.9 |
| 1% | 0.17 M | ≈ 2.8 |
| 3% | 0.50 M | ≈ 2.5 |
| 10% | 1.7 M | ≈ 2.3 |
| 25% | 4.2 M | ≈ 2.1 (ideal-solution estimate; less reliable) |
Why it clouds or gels: the mechanism
- Low charge combined with hydrophobic residues. With about +1 per chain at pH 5–7, repulsion between chains is weak. Six hydrophobic side chains, two of them aromatic, give the chains a reason to associate. Zapadka et al. (the review FDA cites) list pH relative to pI, concentration, temperature, ionic strength and interfaces as the main drivers of peptide aggregation.[13][1]
- Concentration. Aggregation is concentration-dependent. The 2 mg/mL COA figure sets a practical ceiling for water.[1] Supplier figures vary: InvivoChem gives >1 mg/mL in water, and TargetMol’s datasheet gives 5 mM (≈ 9 mg/mL) ‘with sonication recommended’.[9] Treat any figure above 2 mg/mL as conditional on that lot and that method.
- Which liquid touches the powder first. When a neutral diluent hits the dry cake, the surface hydrates at low charge and can form a gel layer that slows wetting of the interior. This explains why order matters. It is a mechanistic inference that fits the general guidance, not something measured on AOD9604.
- Interfaces. Shaking and foaming create air–water interface, where peptides concentrate and can unfold or nucleate aggregates. Glass and plastic surfaces also adsorb cationic peptides, so losses are proportionally largest in dilute solutions.[13][15]
- Disulfide chemistry. The impurities most often reported for AOD9604 are reduced (open) forms, dimers and disulfide-linked aggregates.[1] Thiol–disulfide exchange needs a thiolate nucleophile, so it speeds up as pH approaches and exceeds the cysteine thiol pKa (about 8–9). A small fraction of reduced peptide therefore seeds scrambling far more readily in basic solution than in acid.[14]
- Preservatives. Bacteriostatic water contains 0.9% benzyl alcohol.[17] Benzyl alcohol is a documented aggregation promoter for some proteins.[16] No AOD9604-specific data exist, so treat this as a plausible contributor rather than an established cause.
What the primary sources actually say
| Source | What it reports | Bench implication |
|---|---|---|
| FDA PCAC memo (2024)[1] | Water solubility up to 2 mg/mL (free base and acetate COAs). Sensitive to pH, temperature, concentration and excipients. Main impurities are reduced disulfide, dimers and aggregates. SEC or field-flow fractionation recommended for aggregates | Keep stocks at or below about 2 mg/mL. Purity by RP-HPLC alone cannot rule out aggregates |
| Originator patent WO2007/033427[6] | Crude peptide dissolved in 25% aqueous acetic acid before lyophilisation; cyclisation with iodine in 80% acetic acid; RP-HPLC in 0.1% TFA. For clinical use the acetate was converted to an HCl salt in 10 mM HCl. Dry HCl formulations degraded at room temperature within 3 months, with Gln deamidation as the main pathway plus acid hydrolysis. Adding free-base arginine extended stability to more than 12 months, but the highest-arginine blend was hazy and did not fully dissolve | Acid is the originator’s own processing solvent, but long acid exposure at room temperature degrades the peptide. Pushing pH up too far causes haze |
| Cayman 36790[7][8] | Supplied as acetate solid; slightly soluble in DMSO; prepare stocks in a solvent purged with inert gas; −20 °C, ≥ 4 years | DMSO is a poor first choice. Protect solutions from oxygen |
| InvivoChem V11415[9] | H2O > 1 mg/mL; acetate 1875.13, free base 1815.10; solution storage −80 °C for 6 months, −20 °C for 1 month | Consistent with the FDA figure. The solution timelines are generic supplier defaults, not AOD-specific data |
| Bachem[10] | Basic peptides: a small amount of acetic acid or TFA, then dilute. PBS pH 7.0–7.4 works if ≤ 1 mg/mL is enough. Peptides with free Cys: degassed acidic buffers | Supports acid first. Neutral buffer is acceptable only for dilute final solutions |
| GenScript[11][12] | Net charge above 0: water first, then 10–30% acetic acid, then a little DMSO, then dilute. No NH4OH for Cys peptides. Stock 1–2 mg/mL; aliquot and store at −80 °C; O2-free for Cys | 10–30% is a wetting strength, not a final composition. The 1–2 mg/mL stock target matches the FDA figure |
| Cox 2015; Vanhee 2014[18][19] | LC-MS methods for AOD9604. Cox reduced the disulfide with DTT and measured folded and linear forms. Vanhee characterised seized material | Precedent for the intact plus DTT-reduced MS check described below |
Solvent choice, including bacteriostatic water
| Solvent | Verdict | Why |
|---|---|---|
| 0.6–1% acetic acid (as a wetting volume, then dilute) | First choice | pH ≈ 2.8–2.9 gives about +2.7 to +3 per chain. Volatile and compatible with LC-MS[10][11] |
| 10–30% acetic acid | Rescue only, in a small volume | Little extra charge beyond 1%; more acid exposure. GenScript’s tier for stubborn basic peptides[11][6] |
| Sterile water alone | Conditional, ≤ 1–2 mg/mL | Matches the COA figure. The acetate counter-ion makes the solution mildly acidic[1][9] |
| Bacteriostatic water (0.9% benzyl alcohol, pH 4.5–7.0, unbuffered) | Conditional, as the diluent after acid wetting | Near-neutral pH means about +1 charge; benzyl alcohol may promote aggregation. Its role is preservation for repeated sampling, not dissolution[17][26][16] |
| PBS / neutral buffer as the first liquid | Avoid as first contact | Lowest charge and added salt screening. Acceptable as the final diluent at ≤ 1 mg/mL[10] |
| DMSO | Not recommended | Cayman: slightly soluble[8]; TargetMol datasheet T7815L: insoluble |
| Ammonium hydroxide / basic buffer | Avoid | Charge near zero at pH 8–10; thiolate-driven disulfide exchange[11][14] |
Acid-first laboratory method

- Plan the concentration from net peptide content. Use the COA’s peptide content, not the gross powder mass, and aim for a final concentration of ≤ 1–2 mg/mL of peptide. Example: a 5 mg gross vial at 80% peptide content holds 4.0 mg, or 2.20 µmol at 1815.1 g/mol. Made up to 2.0 mL, that is 2.0 mg/mL (1.10 mM).
- Equilibrate. Let the sealed vial reach room temperature, then tap or briefly spin the cake to the bottom.
- Wet with acid. Add 0.6–1% acetic acid, about 10–20% of the final volume, down the vial wall. Use degassed or inert-gas-purged solvent where practical.[8][10]
- Wait, then swirl. Leave for 2–5 minutes, then swirl or roll gently. Do not vortex and do not let it foam.[13]
- Confirm it is clear against both a dark and a light background before you dilute.
- Dilute in portions to the final volume with water or buffer, swirling between additions. If you need neutral buffer, keep the final concentration at or below about 1 mg/mL.[10]
- Record the solvent, the final pH and the time from dissolution to freezing.
- Aliquot and freeze single-use portions promptly. Do not hold acidic stock at room temperature.[6][11]
Troubleshooting decision tree
- Q1. Does the haze clear within about 10 minutes of standing? Yes: it was microbubbles. Do not shake next time. No: go to Q2.
- Q2. Is the peptide concentration above 2 mg/mL? Yes: add diluent to reach ≤ 2 mg/mL, or ≤ 1 mg/mL in buffer. If it clears, the problem was solubility, not quality.[1] No: go to Q3.
- Q3. Was the first liquid neutral (water, BAC water or PBS)? Yes: add 0.6–1% acetic acid to about 10–20% of the volume, wait 5 minutes and swirl. If it clears, the problem was charge or wetting. No (it was already acidic): go to Q4.
- Q4. Is it still hazy in acid at ≤ 1 mg/mL after a brief bath sonication (under 1 minute, kept cool)? Yes: go to Q5. No: continue, then verify recovery (next section).
- Q5. Stop changing the solvent. Centrifuge and measure the supernatant. Low recovery points to an insoluble fraction, from pre-formed aggregates, disulfide-linked oligomers or a different material. Check the COA (intact mass, HPLC, peptide content) and request SEC or LC-MS data from the supplier.[1]
- Special cases. A precipitate that forms only in the fridge means the solution is near its solubility limit, so store it more dilute and frozen. Flakes that appear on dilution into buffer mean the pH jumped too fast; add buffer in smaller portions. A film on the glass suggests adsorption; use low-binding tubes and pre-wet the walls with acid.[15]
Verification: aggregation vs degradation
A clear solution is not proof of anything. Use at least one quantitative check:
| Test | How | Aggregation looks like | Degradation looks like |
|---|---|---|---|
| Recovery by A280 | Centrifuge at ≥ 10,000 × g for 10 min and read the supernatant. Calculated ε280 ≈ 1615 M−1cm−1 (1 Tyr + 1 cystine), so 1 mg/mL gives A280 ≈ 0.89 in a 1 cm cell | Supernatant below the expected value; pellet or haze | Usually normal A280, because chromophores survive |
| Filtration loss | Read A280 or HPLC area before and after a 0.22 µm low-binding (PES/PVDF) filter | Large loss that scales with concentration | Little loss |
| SEC (or field-flow fractionation) | Size-exclusion separation[1] | Earlier-eluting high-molecular-weight peaks | Monomer peak intact; small fragments may elute late |
| RP-HPLC | Total main-peak area against a fresh standard | Loss of total area with no new peaks (aggregates retained or filtered out) | New peaks: deamidation (Gln6→Glu, +0.984 Da) near the main peak; the reduced form shifts in retention |
| Intact LC-MS | Monoisotopic M 1813.860; [M+2H]2+ m/z 907.94; [M+3H]3+ 605.63[2] | Disulfide-linked dimer at 3627.72 Da. Its 4+ ion falls at m/z 907.94, the same as the monomer 2+. Isotope spacing tells them apart: 0.25 for the dimer, 0.50 for the monomer | +2.016 Da (reduced, 1815.876), +0.984 (deamidated), −163.06 (des-Tyr) |
| DTT reduction then MS | Reduce, then re-analyse, as in Cox 2015[18] | The dimer collapses to the reduced monomer | Confirms that the original disulfide was intact if the shift is exactly +2.016 Da |
Storage
- Solid: −20 °C, dry and dark. Cayman gives ≥ 4 years. The Particle Peptides SDS, cited by FDA, gives −18 °C for 3 years, 0–7 °C for 1 year and 7–30 °C for 6 months.[8][1]
- Solution: No AOD9604-specific solution stability data have been published. Supplier defaults such as InvivoChem’s (−80 °C for 6 months, −20 °C for 1 month) are generic.[9] Claims of ’28 days in the fridge’ have no source behind them. See what evidence should support stability claims.
- Acid exposure: Freeze acidic stocks promptly. The originator saw Gln deamidation and acid hydrolysis even in the dry HCl form at room temperature.[6]
- Oxygen: Use inert-gas-purged solvents. Avoid repeated freeze–thaw cycles.[8][11]
Myths versus evidence
| Claim | Evidence |
|---|---|
| ‘AOD9604 is HGH Fragment 176-191 without the tyrosine.’ | Wrong. Native residue 176 is Phe. AOD9604 is Tyr + 177–191, and commercial ‘Frag 176-191’ is often the same sequence. Check intact mass, not the label.[5][1] |
| ‘BAC water is the reason it clouds.’ | Usually not on its own. A common preparation of 5 mg in 2 mL (2.5 mg/mL) exceeds the 2 mg/mL figure. BAC water is unbuffered and near neutral, which is the low-charge zone.[1][17] |
| ‘More acid is better; use 25%.’ | Little extra charge comes from going above 1% (pH 2.8 against 2.1), and longer acid exposure risks deamidation and hydrolysis.[6] |
| ‘If it clears after a day in the fridge, it’s fine.’ | Clearing is not evidence of integrity. Check recovery, and use SEC or MS.[1] |
| ‘DMSO dissolves everything.’ | Cayman: slightly soluble[8]. TargetMol (datasheet T7815L): insoluble. |
| ‘pI 9.5 means it is insoluble at neutral pH.’ | It still carries about +1 at pH 7. Below about 1 mg/mL, neutral solutions are often fine; the risk rises with concentration.[10] |
| ‘Cloudy means fake.’ | Not necessarily. Rule out concentration and solvent first, then verify identity. |
| ‘Ammonia helps stubborn peptides.’ | Only acidic ones. For AOD9604 it lowers the charge to near zero and favours disulfide exchange.[11][14] |
How this guide differs from common advice
We reviewed the top results for ‘aod9604 reconstitution’, ‘aod 9604 acetic acid’, ‘aod9604 cloudy’ and ‘aod9604 bacteriostatic water’. They include vendor product pages, blog guides, calculators, forum threads and the FDA memo. Below is the gap matrix (✓ = covered, ✗ = not covered).
| Topic | Typical vendor / blog guides | Calculator pages | FDA memo | This guide |
|---|---|---|---|---|
| Cites the 2 mg/mL water figure | A minority (3 pages reviewed) | ✗ | ✓ | ✓ |
| Charge or pI calculation with method | ✗ | ✗ | ✗ | ✓ (3 sets) |
| Explains why acid works, quantitatively | ✗ (‘from practice’) | ✗ | ✗ | ✓ |
| Originator patent solvent and degradation data | ✗ | ✗ | ✗ | ✓ |
| What BAC water contains and does | Partial | Partial | ✗ | ✓ |
| Decision tree | ✗ (lists only) | ✗ | ✗ | ✓ |
| Aggregation vs degradation tests | ✗ | ✗ | Partial (SEC) | ✓ |
| MS m/z values, including the dimer overlap | ✗ | ✗ | ✗ | ✓ |
| Free of dosing or administration content | Mostly ✗ | ✗ | n/a | ✓ |
Glossary
- pI (isoelectric point): the pH at which net charge is zero, usually the point of lowest solubility.
- Net charge (z): the sum of fractional charges at a given pH.
- Disulfide: a covalent S–S bond between two cysteines (here Cys7–Cys14).
- Thiol–disulfide exchange: attack of a thiolate on a disulfide, which can scramble bonds or form dimers. It is favoured at high pH.
- Aggregation: reversible or irreversible self-association, ranging from soluble oligomers to visible particles or gel.
- Deamidation: conversion of Gln or Asn to Glu or Asp, +0.984 Da.
- Peptide content: the mass fraction of the powder that is peptide; the rest is counter-ion and water.
- Bacteriostatic water: sterile water with 0.9% benzyl alcohol as a preservative.
- SEC: size-exclusion chromatography, which separates species by size.
- RP-HPLC: reversed-phase HPLC, used to measure purity by hydrophobicity.
Frequently asked questions
Why is my AOD9604 cloudy after reconstitution?
The most common causes are a concentration above the roughly 2 mg/mL water figure cited by FDA, a neutral diluent touching the powder first, and agitation. AOD9604 carries only about +1 net charge between pH 5 and 7 and has six hydrophobic residues, so chains can associate. Microbubbles clear within minutes; true haze does not.
Can AOD9604 be mixed with bacteriostatic water?
For laboratory stocks, bacteriostatic water (0.9% benzyl alcohol, unbuffered, pH 4.5–7.0) works better as the diluent after acid wetting than as the first liquid, and the final concentration should be kept at or below about 2 mg/mL. Benzyl alcohol is a known aggregation promoter for some proteins, although no AOD9604-specific data exist.
How much acetic acid is used for AOD9604 in the lab?
A small wetting volume of 0.6–1% acetic acid (pH about 2.8–2.9), roughly 10–20% of the final volume, followed by dilution. GenScript allows 10–30% for stubborn basic peptides, but stronger acid adds little extra charge and increases degradation risk.
Why does acetic acid help AOD9604 dissolve?
At pH about 2.9 the C-terminus and Glu11 are protonated, so net charge rises from about +1 to about +2.7–3 per chain. The extra repulsion keeps chains apart. The disulfide is also more stable in acid because thiol–disulfide exchange needs a thiolate.
Is cloudy AOD9604 ruined?
Not necessarily. Persistent haze can be a solubility problem or pre-formed aggregates. Follow the decision tree, then verify supernatant recovery and identity by A280, SEC or LC-MS. Clearing alone does not prove integrity.
What is the isoelectric point of AOD9604?
About 8.8–9.9 depending on the pKa set (Lehninger 9.88, EMBOSS 8.80, Bjellqvist 8.75), calculated with the cysteines excluded because they form a disulfide. Tools that count the cysteines as free report about 8.1.
Is AOD9604 the same as HGH Fragment 176-191?
Commercially they are often the same sequence, YLRIVQCRSVEGSCGF. The native hGH 176–191 starts with Phe, not Tyr. An intact-mass measurement (1815.1 g/mol for the Tyr version) resolves which one you have.
How long is reconstituted AOD9604 stable?
No AOD9604-specific solution stability data have been published. Store single-use aliquots frozen (GenScript suggests −80 °C) and avoid freeze–thaw cycles. Treat fixed day counts as unsupported unless they come with batch data.
Can you shake AOD9604 to dissolve it?
No. Shaking creates air–water interface, which promotes aggregation. Swirl or roll gently, and use brief, cool bath sonication only as a rescue step.
References
- U.S. FDA. Pharmacy Compounding Advisory Committee briefing memo: AOD-9604 (free base) and AOD-9604 acetate. Meeting of 4 December 2024 (PDF). https://www.fda.gov/media/183584/download
- PubChem CID 71300630: AOD-9604, C78H123N23O23S2, 1815.1 g/mol, monoisotopic mass 1813.860. https://pubchem.ncbi.nlm.nih.gov/compound/71300630
- PubChem CID 156599045: AOD-9604 acetate, C80H127N23O25S2, 1875.1 g/mol. https://pubchem.ncbi.nlm.nih.gov/compound/156599045
- FDA/NCATS Global Substance Registration System: AOD-9604, UNII 7UP768IP4M. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/7UP768IP4M
- UniProtKB P01241, Somatotropin (human growth hormone): sequence and disulfide annotation. https://www.uniprot.org/uniprotkb/P01241/entry
- Metabolic Pharmaceuticals Ltd (Hofmann et al.). WO 2007/033427, stable formulations of the hGH 177–191 analogue (priority 2005). WIPO Patentscope. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2007033427
- Cayman Chemical. AOD-9604 (acetate), item 36790, product page. https://www.caymanchem.com/product/36790
- Cayman Chemical. AOD-9604 (acetate), item 36790, product information sheet (PDF). https://cdn.caymanchem.com/cdn/insert/36790.pdf
- InvivoChem. AOD9604 acetate, cat. V11415: physicochemical and solubility data. https://www.invivochem.com/aod9604.html
- Bachem Knowledge Center. Peptide solubility. https://www.bachem.com/knowledge-center/peptide-solubility/
- GenScript. Peptide solubility guidelines, 2023 V1.0 (PDF). https://www.genscript.com/gsfiles/techfiles/GenScript_peptide_solubility_guidelines.pdf
- GenScript. Guidelines for dissolving peptides (PDF). https://www.genscript.com/site2/document/12464_20100407015038.PDF
- Zapadka K.L., Becher F.J., Gomes dos Santos A.L., Jackson S.E. Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus 2017;7:20170030. https://pmc.ncbi.nlm.nih.gov/articles/PMC5665799/
- Nagy P. Kinetics and mechanisms of thiol–disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. Antioxid Redox Signal 2013;18:1623–1641. https://pmc.ncbi.nlm.nih.gov/articles/PMC3613173/
- Kristensen K., Henriksen J.R., Andresen T.L. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLoS One 2015;10:e0122419. https://pmc.ncbi.nlm.nih.gov/articles/PMC4416745/
- Roy S., Katayama D., Dong A., Kerwin B.A., Randolph T.W., Carpenter J.F. Temperature dependence of benzyl alcohol- and ANS-induced aggregation of recombinant human interleukin-1 receptor antagonist. Biochemistry 2006;45:3898–3911. https://pubmed.ncbi.nlm.nih.gov/16548517/
- Pfizer (Hospira). Bacteriostatic Water for Injection, USP: description (0.9% benzyl alcohol, pH 5.7, range 4.5–7.0). https://www.pfizermedical.com/bacteriostatic-water/description
- Cox H.D., Smeal S.J., Hughes C.M., Cox J.E., Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal 2015;7:31–38. https://pubmed.ncbi.nlm.nih.gov/25208511/
- Vanhee C., Moens G., Deconinck E., De Beer J.O. Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604. Drug Test Anal 2014;6:964–968. https://pubmed.ncbi.nlm.nih.gov/24976118/
- Heffernan M. et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and β3-AR knock-out mice. Endocrinology 2001;142:5182–5189. (Cited for synthesis and structure only.) https://pubmed.ncbi.nlm.nih.gov/11713213/
- Stier H., Vos E., Kenley D. Safety and tolerability of the hexadecapeptide AOD9604 in humans. J Endocrinol Metab 2013;3:7–15. (Cited for nomenclature only.) https://jofem.org/index.php/jofem/article/view/157/194
- EMBOSS data file Epk.dat: pK values used by
iep(mirror of the EMBOSS source). https://raw.githubusercontent.com/kimrutherford/EMBOSS/master/emboss/data/Epk.dat - ExPASy Compute pI/Mw tool (Bjellqvist pK set). https://web.expasy.org/compute_pi/
- Bjellqvist B. et al. The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences. Electrophoresis 1993;14:1023–1031. https://pubmed.ncbi.nlm.nih.gov/8125050/
- DailyMed. Bacteriostatic Water injection, solution: label. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87d6e9dc-fe3b-4593-ac9a-d7493d1959c7
About the author: Written by the SaiyanMed Research Team from the primary sources listed above. Values marked as calculated come from our own scripts. Further reading: Peptide identity beyond the product name and the AOD9604 evidence-based review.
Research Use Only
This article covers laboratory and analytical handling of a research reagent. It is not medical advice and not a protocol for administration to humans or animals. It makes no claims about effects in people.